Study of Patients Treated for Aorta and Peripheral Artery Disease at Asan Medical Center Observing Long-Term Outcomes After Revascularization Procedures

What this Trial Is About

Researchers are conducting a single-center observational study to evaluate the clinical outcomes of patients who have undergone revascularization of the aorta or peripheral arteries at Asan Medical Center. This study includes both retrospective and prospective data collection on approximately 6,000 patients treated for conditions such as thoracic or abdominal aortic aneurysm, aortic dissection, penetrating aortic ulcer, and peripheral artery occlusive disease including chronic limb-threatening ischemia, claudication, and acute limb ischemia. The study collects data on treatments like EVAR, TEVAR, and PTA used for revascularization. Participants will be followed up through hospital visits or telephone calls at 1, 6, and 12 months, then at 3, 5, and up to 10 years after their procedures. The monitoring includes tracking major adverse limb events and any deaths. During follow-up visits, researchers will gather information on outcomes such as death from any cause, major adverse limb events, stroke, myocardial infarction, vascular complications, bleeding, procedure success, limb amputation, and the need for repeat interventions. The study aims to provide long-term clinical results over a 10-year period to better understand patient outcomes after these vascular procedures.

Asan Aorta and Peripheral Registry